logo-loader

Little Green Pharma marks first UK export of its medicines soon after listing on ASX

Published: 01:05 21 Apr 2020 AEST

Little Green Pharma's (ASX:LGP) Fleta Solomon tells Proactive's Andrew Scott they joined the Australian Securities Exchange earlier this year and it was a recognition for them of what she describes as a huge vision ahead and how they needed capital to support it.

''We're the first and currently only company in Australia to be producing locally-grown cannabinoid medicines for patient use'', she says.

''We had the vision to not only be a producer but also supplier of cannabinoid medicines ... it wasn't just Australia we wanted to distribute into, we wanted to go further afield and have patients all across the globe benefiting from our medicines''.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

9 hours, 57 minutes ago